![Mark Reddish](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Reddish
Directeur des opérations chez
Metrodora Therapeutics, Inc.
Profil
Mark Reddish is currently working as Vice President-Operation at Metrodora Therapeutics, Inc. He previously worked as Senior Director-Research Immunology at Biomira, Inc. from 1991 to 1998, Vice President-Product Development at ID Biomedical Corp.
from 1998 to 2005, and as an Independent Director at Marker Therapeutics, Inc. from 2014 to 2018.
He completed his undergraduate degree from the University of Massachusetts.
Postes actifs de Mark Reddish
| Sociétés | Poste | Début |
|---|---|---|
Metrodora Therapeutics, Inc. | Directeur des opérations | - |
Anciens postes connus de Mark Reddish
| Sociétés | Poste | Fin |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/10/2018 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Corporate Officer/Principal | 01/01/2005 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Corporate Officer/Principal | 01/01/1998 |
Formation de Mark Reddish
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Health Services |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metrodora Therapeutics, Inc. |
